Long term anti-vascular endothelial growth factor receptor treatment impairs renal function in renal cell carcinoma

被引：0
|
作者：
Naito, S. [1 ]
Otake, K. [1 ]
Tsuchiya, N. [1 ]
机构：
[1] Yamagata Univ, Fac Med, Dept Urol, Yamagata, Japan
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0334
引用
收藏
页码：S486 / S486
页数：1
相关论文
共 50 条
  • [1] Evaluation of Long-Term Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Injections on Renal Function
    Choi, Daniel
    McGeehan, Brendan
    VanderBeek, Brian L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [2] Renal damage associated with anti-vascular endothelial growth factor treatment
    Panigrahi, Pradeep K.
    Satapathy, Jasmita
    Minj, Anita
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (04) : 608 - 609
  • [3] Beware renal adverse effects of anti-vascular endothelial growth factor treatment
    Keir, Lindsay
    van Moorsel, Feike
    Saleem, Moin A.
    Richards, Anna
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [4] Anti-Vascular Endothelial Growth Factor Therapy and Renal Thrombotic Microangiopathy
    Sorenson, Christine M.
    Sheibani, Nader
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (08) : 1082 - 1082
  • [5] Clinical use of vascular endothelial growth factor receptor inhibitors for the treatment of renal cell carcinoma
    Li, Wei
    Feng, Chengguan
    Di, Weihong
    Hong, Shanwen
    Chen, Hui
    Ejaz, Mubashir
    Yang, Yang
    Xu, Tian-rui
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
  • [6] Efficacy and safety of anti-vascular endothelial growth factor therapies in older patients for first line treatment of metastatic renal cell carcinoma
    Dupuis, Hugo Georges Arthur
    Chebbi, Ala
    Surlemont, Louis
    Rigal, Olivier
    Di Fiore, Frederic
    Pfister, Christian
    Nouhaud, Francois-Xavier
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (06) : 2418 - 2426
  • [7] Sarcomatoid Dedifferentiation in Metastatic Clear Cell Renal Cell Carcinoma and Outcome on Treatment With Anti-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Retrospective Analysis
    Beuselinck, Benoit
    Lerut, Evelyne
    Wolter, Pascal
    Dumez, Herlinde
    Berkers, Johannes
    Van Poppel, Hendrik
    Joniau, Steven
    Oyen, Raymond
    De Wever, Liesbeth
    Strijbos, Michiel
    Paridaens, Robert
    Schoffski, Patrick
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : E205 - E214
  • [8] Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease
    Rachael Ann O’Neill
    Patrick Gallagher
    Tricia Douglas
    Julie-Anne Little
    Alexander Peter Maxwell
    Giuliana Silvestri
    Gareth McKay
    BMC Nephrology, 20
  • [9] Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease
    O'Neill, Rachael Ann
    Gallagher, Patrick
    Douglas, Tricia
    Little, Julie-Anne
    Maxwell, Alexander Peter
    Silvestri, Giuliana
    Mckay, Gareth
    BMC NEPHROLOGY, 2019, 20 (01)
  • [10] Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
    Lu-Emerson, Christine
    Duda, Dan G.
    Emblem, Kyrre E.
    Taylor, Jennie W.
    Gerstner, Elizabeth R.
    Loeffler, Jay S.
    Batchelor, Tracy T.
    Jain, Rakesh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (10) : 1197 - 1213
12345